As of 12:30 PM on the 18th, Jinwon Life Sciences is trading at 27,750 KRW, down 4.15% from the previous day. This represents a 96.81% increase compared to August 21. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Today, foreigners are tentatively recorded as net sellers of 14,000 shares. Over the past five days, individual investors have net sold 552,372 shares, while foreigners and institutions have net bought 475,398 shares and 55,767 shares, respectively.
On September 10, Jinwon Life Sciences became a market topic with the news of the 'Inovio COVID-19 vaccine candidate 100 million dose production agreement...'


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
